Pathophysiology and Infection Cycle of SARS-CoV-2

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a novel, enveloped, positive-sense single-stranded RNA virus belonging to the Coronaviridae family , responsible for the global COVID-19 pandemic. It primarily targets the respiratory system and can lead to multisystem involvement , especially in severe cases.

Infection Cycle of SARS-CoV-2

The SARS-CoV-2 infection follows a multi-step cycle:

1. Viral Entry (Invasion)
2. Viral Replication
3. Direct Cytopathic Effects
4. Dysregulated Immune Response (Cytokine Storm)

Viral Entry (Invasion)

• The spike (S) glycoprotein on the SARS-CoV-2 surface is critical for cell entry .
• The S protein is cleaved into S1 and S2 subunits by host proteases .
  • S1 binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host epithelial cells (abundant in lungs, heart, kidneys).
  • S2 mediates membrane fusion , aided by TMPRSS2 (Transmembrane Serine Protease 2) .
• The virus enters cells via endocytosis or membrane fusion .

🧠 High-Yield Note : ACE2 not only facilitates viral entry but also modulates the renin-angiotensin system, influencing inflammation and vasoconstriction.

Viral Replication and Protein Synthesis

• After entry, viral RNA is released into the cytoplasm.
• The 5′ two-thirds of the genome encodes two polyproteins : pp1a and pp1ab , which are cleaved by viral proteases:
  • 3CLPro (Main Protease, Mpro)
  • PLPro (Papain-like Protease)
• These polyproteins are processed into 16 non-structural proteins (nsps) that form the replication-transcription complex (RTC) .
• The RTC synthesizes:
  • Full-length negative-sense RNA template
  • Subgenomic RNAs for structural proteins

Structural proteins (encoded at the 3′ end):

• Spike (S) – mediates host cell entry
• Envelope (E) – viral assembly and release
• Membrane (M) – gives virus its shape
• Nucleocapsid (N) – binds RNA genome
• Assembly occurs in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) .
• Virions are released via exocytosis .

Direct Cytopathic Effects

• Viral replication causes apoptosis and necrosis of infected epithelial and endothelial cells, particularly in the alveoli .
• This leads to alveolar damage , impaired gas exchange , and in severe cases, multi-organ injury due to widespread viral dissemination.

Dysregulated Immune Response (Cytokine Storm)

• Viral antigens are processed by antigen-presenting cells (APCs) , triggering the release of pro-inflammatory cytokines and chemokines , including:
  • IL-1
  • IL-6
  • CXCL10
  • TNF-α
• An exaggerated immune response— cytokine storm syndrome —causes widespread tissue damage , especially in the lungs, leading to:
  • Acute Respiratory Distress Syndrome (ARDS)
  • Multiorgan Failure

🧠 Clinical Insight :

• The severity of COVID-19 correlates strongly with immune dysregulation , not just viral load.
• Patients with comorbidities (e.g., obesity, diabetes, cardiovascular disease) are more prone to cytokine storm.

Therapeutic Interventions Based on Pathogenesis

• IL-6 Inhibitors : Block the cytokine storm and prevent lung injury in severe COVID-19 cases.
  • Tocilizumab and Sarilumab
• Corticosteroids (e.g., dexamethasone): Reduce mortality in patients requiring supplemental oxygen or mechanical ventilation.
• Antivirals (e.g., Remdesivir): Target the viral RNA-dependent RNA polymerase.
• Monoclonal Antibodies : Target spike protein, blocking viral entry.
• Hydroxychloroquine : Initially explored for its immunomodulatory effects, but no longer recommended due to lack of efficacy and safety concerns (per current guidelines from WHO and NIH).

---